Literature DB >> 18584517

Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.

Jan Martínek1, Marek Benes, Tomás Hucl, Pavel Drastich, Petr Stirand, Julius Spicák.   

Abstract

OBJECTIVE: To investigate whether gastroesophageal reflux disease (GERD) with mild to moderate erosive esophagitis (ERD) is a more severe disease regarding the amount of acid reflux, motor abnormalities, and the presence/absence of hiatus hernia than non-erosive reflux disease (NERD).
MATERIAL AND METHODS: The study comprised a retrospective analysis of prospectively collected data on 313 consecutive subjects referred for endoscopy, pH-metry, and esophageal manometry. The patients were divided into four groups: Group I (n=92), subjects without GERD with normal pH-metry, without esophagitis and without reflux symptoms; Group II (n=111), patients with NERD (no esophagitis, abnormal pH-metry); Group III (n=77), patients with mild to moderate ERD (LA A, B; abnormal pH-metry); Group IV (n=33), patients with severe or complicated esophagitis (LA C, D; Barrett's esophagus). All data are expressed as medians with 5th-95th percentiles.
RESULTS: No difference was found in the amount of acid reflux between patients with mild to moderate ERD and those with NERD. The DeMeester score was 34.5 (17-105) in NERD patients and 31.6 (15-102) in ERD patients. No significant differences were found between NERD and ERD patients regarding lower esophageal sphincter (LES) basal pressure (11.6 mmHg; 3-25 in NERD versus 10.7 mmHg; 3-22 in ERD). Similar proportions of patients with NERD and ERD had low LES basal pressure (20.7% in NERD versus 24.7% in ERD; NS) and hiatus hernia (44% and 56%; NS). A relatively high proportion of patients without GERD (Group I) had ineffective esophageal motility (39%) and hiatus hernia (30%).
CONCLUSIONS: No difference was found between NERD and mild to moderate ERD in terms of acid exposure time and esophageal motor abnormalities. To a certain extent, ERD is a "more complicated" form of the disease. Host factors related to a particular patient (e.g. mucosal defense, genetics, acid clearance) might be responsible for the development of esophagitis.

Entities:  

Mesh:

Year:  2008        PMID: 18584517     DOI: 10.1080/00365520801908928

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Basal lower esophageal sphincter pressure in gastroesophageal reflux disease: An ignored metric in high-resolution esophageal manometry.

Authors:  Mayank Jain; M Srinivas; Piyush Bawane; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2018-11-06

2.  Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.

Authors:  David R Braxton; Dana C Nickleach; Yuan Liu; Alton B Farris
Journal:  Virchows Arch       Date:  2014-05-27       Impact factor: 4.064

Review 3.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

4.  Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.

Authors:  Vittorio Bresadola; Gian Luigi Adani; Francesco Londero; Cosimo Alex Leo; Vittorio Cherchi; Dario Lorenzin; Anna Rossetto; Gianmatteo Vit; Umberto Baccarani; Giovanni Terrosu; Dino De Anna
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

5.  A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.

Authors:  Abdallah A Kobeissy; Jana G Hashash; Faek R Jamali; Assaad M Skoury; Reham Haddad; Sarah El-Samad; Rami Ladki; Rola Aswad; Assaad M Soweid
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

6.  Manometric findings in patients with isolated distal gastroesophageal reflux.

Authors:  Yasemin Ozin; Ulku Dagli; Sedef Kuran; Burhan Sahin
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

7.  Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Authors:  I M Modlin; R H Hunt; P Malfertheiner; P Moayyedi; E M Quigley; G N J Tytgat; J Tack; R C Heading; G Holtman; S F Moss
Journal:  Digestion       Date:  2009-06-17       Impact factor: 3.216

8.  Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study.

Authors:  Takashi Joh; Kazuhide Higuchi; Katsuhiko Iwakiri; Takeshi Kamiya; Ken Haruma; Koji Nakada; Noriaki Manabe
Journal:  Sci Rep       Date:  2022-09-03       Impact factor: 4.996

9.  Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides.

Authors:  Francesco Di Pierro; Mario Gatti; Giuliana Rapacioli; Leandro Ivaldi
Journal:  Clin Exp Gastroenterol       Date:  2013-03-27

10.  Esophageal Motor Disorders Are a Strong and Independant Associated Factor of Barrett's Esophagus.

Authors:  Camille Bazin; Alban Benezech; Marine Alessandrini; Jean-Charles Grimaud; Veronique Vitton
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.